https://orcid.org/0000-0002-8463-8487
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fabián P. Alvarez, Pierre Chevalier, Matthias Borms, Hélène Bricout, Catia Marques, Anu Soininen, Tatu Sainio, Christine Petit & Caroline de Courville. (2023) Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal. Journal of Medical Economics 26:1, pages 710-719.
Read now
Read now
J. Kevin Yin, Stephanie Pepin, Robertus van Aalst, Matthew M. Loiacono & Sandrine I. Samson. (2022) Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years. Human Vaccines & Immunotherapeutics 18:6.
Read now
Read now
Sanjay Hadigal, Laura Colombo & Scott Haughie. (2022) Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Articles from other publishers (16)
Marina Amaral de Avila Machado, Sonja Gandhi-Banga, Sophie Gallo, Tathyana Giannotti Cousseau, Reddappa Maniganahally Byrareddy, Markku Nissilä, Jörg Schelling & Celine Monfredo. (2024) Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season. Human Vaccines & Immunotherapeutics 20:1.
Crossref
Crossref
Ann R. Falsey, Stefania Maggi & Tor Biering-Sørensen. (2024) Podcast: Need for Quality Evidence for Decision-Making on Seasonal Influenza Vaccines. Infectious Diseases and Therapy.
Crossref
Crossref
Ahmad Raja S Albalawi, Joud Abdulhamid S Alhassun, Raghad K Almarshud, Hamad A Almejali, Salwa M Alharbi, Amal M Shaybah, Zahra Mohammed A Alshehab, Saleh M Alzahrani, Lama S Abomelha, Alwaleed A Almalki, Abdulrahman O Alkhurayyif, Mariyam S Alalawi, Anwar J Alnass, Khalid F Alzibali & Jehad M Alabdulrahim. (2024) Unlocking the Power of Influenza Vaccines for Pediatric Population: A Narrative Review. Cureus.
Crossref
Crossref
Alper Cevirgel, Sudarshan A. Shetty, Martijn Vos, Nening M. Nanlohy, Lisa Beckers, Elske Bijvank, Nynke Rots, Josine van Beek, Anne‐Marie Buisman & Debbie van Baarle. (2023) Pre‐vaccination immunotypes reveal weak and robust antibody responders to influenza vaccination. Aging Cell 23:2.
Crossref
Crossref
Kathrin Pahmeier, Christian Speckemeier, Silke Neusser, Jürgen Wasem & Janine Biermann-Stallwitz. (2023) Vaccinating the German Population Aged 60 Years and Over with a Quadrivalent High-Dose Inactivated Influenza Vaccine Compared to Standard-Dose Vaccines: A Transmission and Budget Impact Model. PharmacoEconomics 41:11, pages 1539-1550.
Crossref
Crossref
Raffaele Antonelli Incalzi, Agostino Consoli, Pierluigi Lopalco, Stefania Maggi, Giorgio Sesti, Nicola Veronese & Massimo Volpe. (2023) Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinion. Internal and Emergency Medicine.
Crossref
Crossref
Kalin M. CliffordMary S. KleinLindsay A. CourtneyAlaina Van DykeMeredith SiglerRachel L. Basinger. (2023) Chronic Obstructive Pulmonary Disease, Part 5: Clinical Pearls for Comorbid COPD. The Senior Care Pharmacist 38:10, pages 404-415.
Crossref
Crossref
Tongling Xiao, Miaomiao Wei, Xiaokun Guo, Yu Zhang, Zhongyan Wang, Xiaoshuang Xia, Xuemei Qi, Lin Wang, Xin Li & Sean X. Leng. (2023) Immunogenicity and safety of quadrivalent influenza vaccine among young and older adults in Tianjin, China: implication of immunosenescence as a risk factor. Immunity & Ageing 20:1.
Crossref
Crossref
Allison L Naleway, Sara S Kim, Brendan Flannery, Min Z Levine, Kempapura Murthy, Suryaprakash Sambhara, Shivaprakash Gangappa, Laura J Edwards, Sarah Ball, Lauren Grant, Tnelda Zunie, Weiping Cao, F Liaini Gross, Holly Groom, Alicia M Fry, Danielle Hunt, Zuha Jeddy, Margarita Mishina, Meredith G Wesley, Sarah Spencer, Mark G Thompson, Manjusha Gaglani & Fatimah S Dawood. (2023) Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture–Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18–65 Years in 2019–2020. Open Forum Infectious Diseases 10:6.
Crossref
Crossref
Thao N. T. Ho, Son H. Pham, Linh T. T. Nguyen, Ha T. Nguyen, Luan T. Nguyen & Tien T. Dang. (2023) Insights into the synthesis strategies of plant-derived cyclotides. Amino Acids 55:6, pages 713-729.
Crossref
Crossref
Andreia N. Cadar, Dominique E. Martin & Jenna M. Bartley. (2023) Targeting the hallmarks of aging to improve influenza vaccine responses in older adults. Immunity & Ageing 20:1.
Crossref
Crossref
Andrea De Vito, Agnese Colpani, Mattia Trunfio, Vito Fiore, Giulia Moi, Marco Fois, Nicola Leoni, Stefano Ruiu, Sergio Babudieri, Andrea Calcagno & Giordano Madeddu. (2023) Living with HIV and Getting Vaccinated: A Narrative Review. Vaccines 11:5, pages 896.
Crossref
Crossref
Leilani Sanchez, Takahiro Nakama, Hideaki Nagai, Osamu Matsuoka, Satoshi Inoue, Takahiro Inoue, Anju Shrestha, Aseem Pandey, Lee-Jah Chang & Iris De Bruijn. (2023) Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial. Vaccine 41:15, pages 2553-2561.
Crossref
Crossref
Marlo Verket, Malte Jacobsen, Katharina Schütt, Nikolaus Marx & Dirk Müller-Wieland. (2023) Influenza vaccination in patients affected by diabetes. European Heart Journal Supplements 25:Supplement_A, pages A36-A41.
Crossref
Crossref
Niklas Dyrby Johansen, Daniel Modin, Joshua Nealon, Sandrine Samson, Camille Salamand, Matthew M. Loiacono, Carsten Schade Larsen, Anne Marie Reimer Jensen, Nino Emanuel Landler, Brian L. Claggett, Scott D. Solomon, Martin J. Landray, Gunnar H. Gislason, Lars Køber, Jens Ulrik Stæhr Jensen, Pradeesh Sivapalan, Lasse Skafte Vestergaard, Palle Valentiner-Branth, Tyra Grove Krause & Tor Biering-Sørensen. (2023) A Pragmatic Randomized Feasibility Trial of Influenza Vaccines. NEJM Evidence 2:2.
Crossref
Crossref
Thomas Theo Brehm & Annette Hennigs. (2022) Saisonale Influenza – Aktuelles zu Epidemiologie, Prävention und Therapie. DMW - Deutsche Medizinische Wochenschrift 147:22, pages 1456-1464.
Crossref
Crossref